Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis.
The unfolded protein response in multiple sclerosis.
[Pegylated interferon beta 1a : A new therapy option for treatment of relapsing-remitting multiple sclerosis].
Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis.
Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health.
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
Th17 cells in central nervous system autoimmunity.
Exercise therapy for fatigue in multiple sclerosis.
ROCK in CNS: different roles of isoforms, and therapeutic target for neurodegenerative disorders.
Treatment with the Immunomodulator FTY720 (Fingolimod) Significantly Reduces Renal Inflammation in Murine Unilateral Ureteral Obstruction.
The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review.
Disruption of Myelin Leads to Ectopic Expression of KV1.1 Channels with Abnormal Conductivity of Optic Nerve Axons in a Cuprizone-Induced Model of Demyelination.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
Effects of whole body vibration on muscle spasticity for people with central nervous system disorders: A systematic review.
Trigeminal neuralgia: A new therapy?
An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
B cell VLA-4-deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity.
Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.
Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients.
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
Prognostic factors of acute partial transverse myelitis-reply.
Visual pathway abnormalities were found in most multiple sclerosis patients despite history of previous optic neuritis.
Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease.
Pages
« first
‹ previous
…
397
398
399
400
401
402
403
404
405
…
next ›
last »